Imatinib (gleevec) - Cancer Science

Relevant Publications

Calculating Protein-Ligand Residence Times Through State Predictive Information Bottleneck based Enhanced Sampling.

Issue Release: 2024

Calculating Protein-Ligand Residence Times through State Predictive Information Bottleneck Based Enhanced Sampling.

Issue Release: 2024

CRISPR-Cas9-Mediated Bioluminescent Tagging of Endogenous Proteins by Fluorescent Protein-Assisted Cell Sorting.

Issue Release: 2024

Stretching the structural envelope of imatinib to reduce β-amyloid production by modulating both β- and γ-secretase cleavages of APP.

Issue Release: 2024

Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia.

Issue Release: 2024

Immunohistochemical expression of CD117/KIT, HER2, and Erβ in schistosomal and non-schistosomal urothelial carcinoma of Egyptian patients.

Issue Release: 2023

Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trial.

Issue Release: 2023

Rare Presentation of a Gastrointestinal Stromal Tumor Encapsulating the Spleen: A Case Report.

Issue Release: 2023

Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary Mutations.

Issue Release: 2023

Protein Flexibility and Dissociation Pathway Differentiation Can Explain Onset of Resistance Mutations in Kinases.

Issue Release: 2022

Cytogenetical and hematological analysis of chronic myelogenous leukemia patients with a novel case 52XX, t (1;9;22) (q23.3; q34; q11.2), +6, +8, i(9) (q10;q10), +18,+19,+21+der22 t(9;22)(q34;q11).

Issue Release: 2022

Assessment of Imatinib as a Primary Treatment of Chronic Myeloid Leukemia in Chronic Phase: a Cohort Study.

Issue Release: 2022

Effect of imatinib on oral wound healing after extraction: A rare case report.

Issue Release: 2022

Are off-target effects of imatinib the key to improving beta-cell function in diabetes?

Issue Release: 2022

Online Pharmacy Accessibility of Imatinib, An Oral Chemotherapy Medication.

Issue Release: 2022

The anticancer drug imatinib induces autophagy in Schistosoma mansoni.

Issue Release: 2021

Gleevec and Rapamycin Synergistically Reduce Cell Viability and Inhibit Proliferation and Angiogenic Function of Mouse Bone Marrow-Derived Endothelial Progenitor Cells.

Issue Release: 2021

Analysis of clinicopathologic features and gene mutations in gastrointestinal stromal tumor: a series of 58 patients.

Issue Release: 2021

Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles.

Issue Release: 2021

Computer Simulations of the Dissociation Mechanism of Gleevec from Abl Kinase with Milestoning.

Issue Release: 2021

How Are Sensitivity and Specificity Calculated?

How can NPCR data be accessed?

What Types of Cancer Can Be Treated with TIL Therapy?

Who Should Not Take Glasdegib?

What Goes Wrong in Cancer Cell Growth?

How Can Cancers Maintain Emotional Balance?

What Role Do Healthcare Professionals Play in Utilizing High-Quality Media?

What is Diet-Related Cancer?

What Are the Treatment Options for IHD in Cancer Patients?

Why is Personalization Important in Cancer Treatment?

Partnered Content Networks

Relevant Topics